Cargando…

Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells

Previous research has indicated that allosteric interactions across the dimer interface of β (1)‐adrenoceptors may be responsible for a secondary low affinity binding conformation. Here we have investigated the potential for probe dependence, in the determination of antagonist pK(i) values at the hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Soave, Mark, Stoddart, Leigh A., Brown, Alastair, Woolard, Jeanette, Hill, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988514/
https://www.ncbi.nlm.nih.gov/pubmed/27588207
http://dx.doi.org/10.1002/prp2.250
_version_ 1782448443122253824
author Soave, Mark
Stoddart, Leigh A.
Brown, Alastair
Woolard, Jeanette
Hill, Stephen J.
author_facet Soave, Mark
Stoddart, Leigh A.
Brown, Alastair
Woolard, Jeanette
Hill, Stephen J.
author_sort Soave, Mark
collection PubMed
description Previous research has indicated that allosteric interactions across the dimer interface of β (1)‐adrenoceptors may be responsible for a secondary low affinity binding conformation. Here we have investigated the potential for probe dependence, in the determination of antagonist pK(i) values at the human β (1)‐adenoceptor, which may result from such allosterism interactions. Three fluorescent β (1)‐adrenoceptor ligands were used to investigate this using bioluminescence energy transfer (BRET) between the receptor‐bound fluorescent ligand and the N‐terminal NanoLuc tag of a human β (1)‐adrenoceptor expressed in HEK 293 cells (NanoBRET). This proximity assay showed high‐affinity‐specific binding to the NanoLuc‐ β (1)‐adrenoceptor with each of the three fluorescent ligands yielding K (D) values of 87.1 ± 10 nmol/L (n = 8), 38.1 ± 12 nmol/L (n = 7), 13.4 ± 2 nmol/L (n = 14) for propranolol‐Peg8‐BY630, propranolol‐ β(Ala‐Ala)‐BY630 and CGP‐12177‐TMR, respectively. Parallel radioligand‐binding studies with (3)H‐CGP12177 and TIRF microscopy, to monitor NanoLuc bioluminescence, confirmed a high cell surface expression of the NanoLuc‐ β (1)‐adrenoceptor in HEK 293 cells (circa 1500 fmol.mg protein(−1)). Following a 1 h incubation with fluorescent ligands and β (1)‐adrenoceptor competing antagonists, there were significant differences (P < 0.001) in the pK(i) values obtained for CGP20712a and CGP 12177 with the different fluorescent ligands and (3)H‐CGP 12177. However, increasing the incubation time to 2 h removed these significant differences. The data obtained show that the NanoBRET assay can be applied successfully to study ligand‐receptor interactions at the human β (1)‐adrenoceptor. However, the study also emphasizes the importance of ensuring that both the fluorescent and competing ligands are in true equilibrium before interpretations regarding probe dependence can be made.
format Online
Article
Text
id pubmed-4988514
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49885142016-08-30 Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells Soave, Mark Stoddart, Leigh A. Brown, Alastair Woolard, Jeanette Hill, Stephen J. Pharmacol Res Perspect Original Articles Previous research has indicated that allosteric interactions across the dimer interface of β (1)‐adrenoceptors may be responsible for a secondary low affinity binding conformation. Here we have investigated the potential for probe dependence, in the determination of antagonist pK(i) values at the human β (1)‐adenoceptor, which may result from such allosterism interactions. Three fluorescent β (1)‐adrenoceptor ligands were used to investigate this using bioluminescence energy transfer (BRET) between the receptor‐bound fluorescent ligand and the N‐terminal NanoLuc tag of a human β (1)‐adrenoceptor expressed in HEK 293 cells (NanoBRET). This proximity assay showed high‐affinity‐specific binding to the NanoLuc‐ β (1)‐adrenoceptor with each of the three fluorescent ligands yielding K (D) values of 87.1 ± 10 nmol/L (n = 8), 38.1 ± 12 nmol/L (n = 7), 13.4 ± 2 nmol/L (n = 14) for propranolol‐Peg8‐BY630, propranolol‐ β(Ala‐Ala)‐BY630 and CGP‐12177‐TMR, respectively. Parallel radioligand‐binding studies with (3)H‐CGP12177 and TIRF microscopy, to monitor NanoLuc bioluminescence, confirmed a high cell surface expression of the NanoLuc‐ β (1)‐adrenoceptor in HEK 293 cells (circa 1500 fmol.mg protein(−1)). Following a 1 h incubation with fluorescent ligands and β (1)‐adrenoceptor competing antagonists, there were significant differences (P < 0.001) in the pK(i) values obtained for CGP20712a and CGP 12177 with the different fluorescent ligands and (3)H‐CGP 12177. However, increasing the incubation time to 2 h removed these significant differences. The data obtained show that the NanoBRET assay can be applied successfully to study ligand‐receptor interactions at the human β (1)‐adrenoceptor. However, the study also emphasizes the importance of ensuring that both the fluorescent and competing ligands are in true equilibrium before interpretations regarding probe dependence can be made. John Wiley and Sons Inc. 2016-08-08 /pmc/articles/PMC4988514/ /pubmed/27588207 http://dx.doi.org/10.1002/prp2.250 Text en © 2016 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Soave, Mark
Stoddart, Leigh A.
Brown, Alastair
Woolard, Jeanette
Hill, Stephen J.
Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
title Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
title_full Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
title_fullStr Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
title_full_unstemmed Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
title_short Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
title_sort use of a new proximity assay (nanobret) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in hek‐293 cells
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988514/
https://www.ncbi.nlm.nih.gov/pubmed/27588207
http://dx.doi.org/10.1002/prp2.250
work_keys_str_mv AT soavemark useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells
AT stoddartleigha useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells
AT brownalastair useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells
AT woolardjeanette useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells
AT hillstephenj useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells